Intraocular Lens Market by Type (Monofocal IOLs (Spheric Monofocal IOLs), Premium IOLs (Accommodating IOLs)), Material (Hydrophobic Acrylic IOLs, PolyMethylMethAcrylate, Silicon IOLs), Application (Presbyopia), End User (Hospitals) - Global Forecast to 2030

1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 26 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 26 1.3.2 INCLUSIONS AND EXCLUSIONS 27 1.3.3 YEARS CONSIDERED 27 1.4 CURRENCY CONSIDERED 28 1.5 STAKEHOLDERS 28 1.6 SUMMARY OF CHANGES 29 2 EXECUTIVE SUMMARY 30 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 30 2.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS 31 2.3 DISRUPTIVE TRENDS SHAPING MARKET 32 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 33 2.5 SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 34 3 PREMIUM INSIGHTS 35 3.1 INTRAOCULAR LENS MARKET OVERVIEW 35 3.2 ASIA PACIFIC: INTRAOCULAR LENS MARKET 36 3.3 INTRAOCULAR LENS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 37 3.4 INTRAOCULAR LENS MARKET: REGIONAL MIX 37 3.5 INTRAOCULAR LENS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 38 4 MARKET OVERVIEW 39 4.1 INTRODUCTION 39 4.2 MARKET DYNAMICS 39 4.2.1 DRIVERS 40 4.2.1.1 Increasing geriatric population and subsequent rise in ophthalmic disorders 40 4.2.1.2 Rising number of cataract surgeries 40 4.2.1.3 Growing technological advancements in intraocular lens 42 4.2.2 RESTRAINTS 42 4.2.2.1 Rising cost of intraocular lenses 42 4.2.3 OPPORTUNITIES 43 4.2.3.1 High growth potential in emerging economies 43 4.2.4 CHALLENGES 43 4.2.4.1 Shortage of skilled ophthalmologists 43 4.3 UNMET NEEDS AND WHITE SPACES 44 4.3.1 UNMET NEEDS IN INTRAOCULAR LENS MARKET 44 4.3.2 WHITE SPACE OPPORTUNITIES 45 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 45 4.4.1 INTERCONNECTED MARKETS 45 4.4.2 CROSS-SECTOR OPPORTUNITIES 46 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 46 5 INDUSTRY TRENDS 47 5.1 PORTER’S FIVE FORCES ANALYSIS 47 5.1.1 BARGAINING POWER OF BUYERS 48 5.1.2 BARGAINING POWER OF SUPPLIERS 48 5.1.3 THREAT OF NEW ENTRANTS 49 5.1.4 THREAT OF SUBSTITUTES 49 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 49 5.2 MACROECONOMIC OUTLOOK 49 5.2.1 INTRODUCTION 49 5.2.2 GDP TRENDS AND FORECAST 49 5.2.3 TRENDS IN GLOBAL OPHTHALMIC EQUIPMENT INDUSTRY 51 5.2.4 TRENDS IN GLOBAL CATARACT SURGERY INDUSTRY 51 5.3 SUPPLY CHAIN ANALYSIS 52 5.4 VALUE CHAIN ANALYSIS 53 5.5 ECOSYSTEM ANALYSIS 55 5.6 PRICING ANALYSIS 56 5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 56 5.6.2 AVERAGE SELLING PRICE TREND, BY REGION 57 5.7 TRADE ANALYSIS 57 5.7.1 IMPORT SCENARIO (HS CODE 900290) 57 5.7.2 EXPORT DATA (HS CODE 900290) 58 5.8 KEY CONFERENCES AND EVENTS, 2025–2027 59 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 59 5.10 INVESTMENT AND FUNDING SCENARIO 60 5.11 CASE STUDY ANALYSIS 61 5.11.1 CASE STUDY 1: ENHANCED REFRACTIVE ACCURACY FOR POST-LASIK CATARACT PATIENTS 61 5.11.2 CASE STUDY 2: EXPANDING ACCESS TO CATARACT CARE IN LOW-INCOME REGIONS 61 5.11.3 CASE STUDY 3: DIGITAL WORKFLOW TRANSFORMATION FOR PREMIUM CATARACT SURGERY 62 5.12 IMPACT OF 2025 US TARIFF ON INTRAOCULAR LENS MARKET 62 5.12.1 INTRODUCTION 62 5.12.2 KEY TARIFF RATES 63 5.12.3 PRICE IMPACT ANALYSIS 64 5.12.4 IMPACT ON COUNTRY/REGION 64 5.12.4.1 North America 64 5.12.4.2 Europe 65 5.12.4.3 Asia Pacific 65 5.12.5 END-USE INDUSTRY IMPACT 65 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 66 6.1 KEY EMERGING TECHNOLOGIES 66 6.1.1 NEXT-GENERATION EDOF AND HYBRID OPTIC DESIGNS 66 6.1.2 AI-DRIVEN PERSONALIZED IOL PLANNING AND CALCULATION PLATFORMS 66 6.2 COMPLEMENTARY TECHNOLOGIES 67 6.2.1 ADVANCED BIOMETRY AND DIAGNOSTICS 67 6.3 TECHNOLOGY/PRODUCT ROADMAP 67 6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 67 6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 68 6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 68 6.4 PATENT ANALYSIS 69 6.4.1 JURISDICTION AND TOP APPLICANT ANALYSIS 69 6.4.2 LIST OF PATENTS 70 6.5 FUTURE APPLICATIONS 71 6.5.1 POSTOPERATIVE ADJUSTABLE AND CUSTOMIZABLE INTRAOCULAR LENS 71 6.5.2 REGENERATIVE AND BIOINTEGRATIVE LENS TECHNOLOGIES 72 6.5.3 AI-INTEGRATED DIGITAL SURGICAL ECOSYSTEMS FOR INTRAOCULAR LENS 72 6.6 IMPACT OF AI/GEN AI ON INTRAOCULAR LENS MARKET 73 6.6.1 INTRODUCTION 73 6.6.2 TOP USE CASES AND MARKET POTENTIAL 73 6.6.3 CASE STUDIES OF AI IMPLEMENTATION IN INTRAOCULAR LENS MARKET 74 6.6.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 75 6.6.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN INTRAOCULAR LENS MARKET 75 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 76 7.1 REGIONAL REGULATIONS AND COMPLIANCE 76 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 7.1.2 INDUSTRY STANDARDS 78 7.2 SUSTAINABILITY INITIATIVES 79 7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF INTRAOCULAR LENS 79 7.2.1.1 Carbon impact reduction 79 7.2.1.2 Eco-applications 79   7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 79 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 80 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 81 8.1 DECISION-MAKING PROCESS 81 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 81 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 81 8.2.2 KEY BUYING CRITERIA 82 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 83 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 83 8.5 MARKET PROFITABILITY 84 8.5.1 REVENUE POTENTIAL 84 8.5.2 COST DYNAMICS 84 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 84 9 INTRAOCULAR LENS MARKET, BY TYPE 85 9.1 INTRODUCTION 86 9.2 MONOFOCAL INTRAOCULAR LENSES 86 9.2.1 ASPHERIC MONOFOCAL INTRAOCULAR LENSES 88 9.2.1.1 Increased visual quality and performance to propel market 88 9.2.2 SPHERIC MONOFOCAL INTRAOCULAR LENSES 90 9.2.2.1 Cost-effectiveness to drive market 90 9.3 PREMIUM INTRAOCULAR LENSES 91 9.3.1 MULTIFOCAL INTRAOCULAR LENSES 94 9.3.1.1 Enhanced visual acuity to support growth 94 9.3.2 EXTENDED DEPTH OF FOCUS (EDOF) INTRAOCULAR LENSES 95 9.3.2.1 Broader range of clear vision to drive market 95 9.3.3 ACCOMMODATING INTRAOCULAR LENSES 96 9.3.3.1 High utilization in cataract correction to aid growth 96 9.4 PHAKIC INTRAOCULAR LENSES 97 9.4.1 LIMITED AWARENESS AND COST CONCERNS TO RESTRAIN MARKET 97 9.5 OTHER INTRAOCULAR LENSES 99 10 INTRAOCULAR LENS MARKET, BY MATERIAL 100 10.1 INTRODUCTION 101 10.2 HYDROPHOBIC ACRYLIC IOL 101 10.2.1 INCREASED BIOCOMPATIBILITY AND HEIGHTENED STABILITY TO DRIVE MARKET 101 10.3 HYDROPHILIC ACRYLIC IOL 102 10.3.1 GLARE REDUCTION AND INCREASED COMPRESSIBILITY TO PROPEL MARKET 102 10.4 POLYMETHYLMETHACRYLATE 103 10.4.1 LOW MATERIAL COST AND ADVANCED DURABILITY TO BOOST MARKET 103 10.5 SILICONE IOL 105 10.5.1 LOW AWARENESS AND LIMITED FOLDABILITY TO RESTRAIN MARKET 105 10.6 OTHER MATERIALS 106 11 INTRAOCULAR LENS MARKET, BY APPLICATION 107 11.1 INTRODUCTION 108 11.2 CATARACT SURGERIES 108 11.2.1 RISING GERIATRIC POPULATION TO FACILITATE GROWTH 108 11.3 PRESBYOPIA 110 11.3.1 GROWING AWARENESS OF TECHNOLOGICALLY ADVANCED LENSES TO BOOST MARKET 110 11.4 CORNEAL DISORDERS 111 11.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO SPUR GROWTH 111 11.5 OTHER APPLICATIONS 113 12 INTRAOCULAR LENS MARKET, BY END USER 114 12.1 INTRODUCTION 115 12.2 HOSPITALS 115 12.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO PROPEL MARKET 115 12.3 OPHTHALMOLOGY CLINICS 116 12.3.1 REDUCED WAITING TIME AND MINIMAL COST OF DIAGNOSTIC & SURGICAL PROCEDURES TO DRIVE MARKET 116 12.4 EYE RESEARCH INSTITUTES 118 12.4.1 INCREASING R&D ON INTRAOCULAR LENS TECHNOLOGIES TO ENCOURAGE GROWTH 118 12.5 OTHER END USERS 119 13 INTRAOCULAR LENS MARKET, BY REGION 120 13.1 INTRODUCTION 121 13.2 NORTH AMERICA 121 13.2.1 US 125 13.2.1.1 Favorable reimbursement policies to drive market 125 13.2.2 CANADA 127 13.2.2.1 Large target population to fuel market 127 13.3 EUROPE 130 13.3.1 GERMANY 132 13.3.1.1 Increasing public healthcare expenditure to aid growth 132 13.3.2 FRANCE 135 13.3.2.1 Government initiatives for visual care awareness to support growth 135 13.3.3 UK 138 13.3.3.1 Growing healthcare expenditure to facilitate growth 138   13.3.4 ITALY 140 13.3.4.1 Increasing R&D initiatives for eye care to spur growth 140 13.3.5 SPAIN 143 13.3.5.1 Rising healthcare spending to encourage growth 143 13.3.6 REST OF EUROPE 145 13.4 ASIA PACIFIC 148 13.4.1 JAPAN 151 13.4.1.1 Rising geriatric population to boost demand 151 13.4.2 CHINA 153 13.4.2.1 Improved healthcare infrastructure to support growth 153 13.4.3 INDIA 156 13.4.3.1 Rising number of cataract surgeries to drive market 156 13.4.4 AUSTRALIA 158 13.4.4.1 High focus on R&D for advanced IOLs to fuel market 158 13.4.5 SOUTH KOREA 160 13.4.5.1 Rising adoption of technologically advanced intraocular lenses to boost market 160 13.4.6 REST OF ASIA PACIFIC 163 13.5 LATIN AMERICA 165 13.5.1 BRAZIL 168 13.5.1.1 Government initiatives for healthcare infrastructure to boost market 168 13.5.2 MEXICO 170 13.5.2.1 Rising incidence of chronic diseases to support growth 170 13.5.3 REST OF LATIN AMERICA 172 13.6 MIDDLE EAST & AFRICA 175 13.6.1 EXPANDING ACCESS TO VISION CARE TO ACCELERATE GROWTH 175 13.7 GCC COUNTRIES 177 13.7.1 RISE IN CAMPAIGNS TO BOOST AWARENESS FOR CATARACT SURGERIES AND TREATMENT TO DRIVE MARKET 177 14 COMPETITIVE LANDSCAPE 180 14.1 OVERVIEW 180 14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN 180 14.3 REVENUE ANALYSIS, 2020–2024 182 14.4 MARKET SHARE ANALYSIS, 2024 183 14.5 US MARKET SHARE ANALYSIS 184 14.6 BRAND/PRODUCT COMPARISON 186 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 187 14.7.1 STARS 187 14.7.2 EMERGING LEADERS 187 14.7.3 PERVASIVE PLAYERS 187 14.7.4 PARTICIPANTS 187   14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 189 14.7.5.1 Company footprint 189 14.7.5.2 Region footprint 190 14.7.5.3 Type footprint 191 14.7.5.4 Material footprint 192 14.7.5.5 Application footprint 193 14.7.5.6 End-user footprint 194 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 195 14.8.1 PROGRESSIVE COMPANIES 195 14.8.2 RESPONSIVE COMPANIES 195 14.8.3 DYNAMIC COMPANIES 195 14.8.4 STARTING BLOCKS 195 14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 197 14.8.5.1 Detailed list of key startups/SMEs 197 14.8.5.2 Competitive benchmarking of key startups/SMEs 198 14.9 COMPANY VALUATION AND FINANCIAL METRICS 198 14.9.1 COMPANY VALUATION 198 14.9.2 FINANCIAL METRICS 199 14.10 COMPETITIVE SCENARIO 199 14.10.1 PRODUCT LAUNCHES AND APPROVALS 199 14.10.2 DEALS 201 14.10.3 EXPANSIONS 203 15 COMPANY PROFILES 204 15.1 KEY PLAYERS 204 15.1.1 ALCON 204 15.1.1.1 Business overview 204 15.1.1.2 Products offered 205 15.1.1.3 Recent developments 206 15.1.1.3.1 Product launches and approvals 206 15.1.1.3.2 Deals 206 15.1.1.4 MnM view 207 15.1.1.4.1 Key strengths/Right to win 207 15.1.1.4.2 Strategic choices 207 15.1.1.4.3 Weaknesses/Competitive threats 207 15.1.2 JOHNSON & JOHNSON VISION CARE, INC. 208 15.1.2.1 Business overview 208 15.1.2.2 Products offered 209 15.1.2.3 Recent developments 210 15.1.2.3.1 Product launches and approvals 210   15.1.2.4 MnM view 210 15.1.2.4.1 Key strengths/Right to win 210 15.1.2.4.2 Strategic choices 210 15.1.2.4.3 Weaknesses/Competitive threats 210 15.1.3 BAUSCH + LOMB 211 15.1.3.1 Business overview 211 15.1.3.2 Products offered 212 15.1.3.3 Recent developments 213 15.1.3.3.1 Product launches and approvals 213 15.1.3.3.2 Deals 213 15.1.3.4 MnM view 214 15.1.3.4.1 Key strengths/Right to win 214 15.1.3.4.2 Strategic choices 214 15.1.3.4.3 Weaknesses/Competitive threats 214 15.1.4 CARL ZEISS MEDITEC AG 215 15.1.4.1 Business overview 215 15.1.4.2 Products offered 216 15.1.4.3 Recent developments 216 15.1.4.3.1 Product launches and approvals 216 15.1.4.3.2 Deals 217 15.1.4.4 MnM view 217 15.1.4.4.1 Key strengths/Right to win 217 15.1.4.4.2 Strategic choices 217 15.1.4.4.3 Weaknesses/Competitive threats 217 15.1.5 HOYA CORPORATION 218 15.1.5.1 Business overview 218 15.1.5.2 Products offered 219 15.1.5.3 Recent developments 220 15.1.5.3.1 Deals 220 15.1.5.4 MnM view 220 15.1.5.4.1 Key strengths/Right to win 220 15.1.5.4.2 Strategic choices 220 15.1.5.4.3 Weaknesses/Competitive threats 220 15.1.6 SANTEN PHARMACEUTICAL CO., LTD. 221 15.1.6.1 Business overview 221 15.1.6.2 Products offered 222 15.1.7 NIDEK CO., LTD. 223 15.1.7.1 Business overview 223 15.1.7.2 Products offered 223 15.1.7.3 Recent developments 224 15.1.7.3.1 Deals 224   15.1.8 LENSTEC, INC. 225 15.1.8.1 Business overview 225 15.1.8.2 Products offered 225 15.1.8.3 Recent developments 225 15.1.8.3.1 Other developments 225 15.1.9 RAYNER GROUP 226 15.1.9.1 Business overview 226 15.1.9.2 Products offered 226 15.1.9.3 Recent developments 227 15.1.9.3.1 Product launches and approvals 227 15.1.10 BVI 228 15.1.10.1 Business overview 228 15.1.10.2 Products offered 228 15.1.10.3 Recent developments 229 15.1.10.3.1 Product launches and approvals 229 15.1.10.3.2 Expansions 229 15.1.11 OPHTEC B.V. 230 15.1.11.1 Business overview 230 15.1.11.2 Products offered 230 15.1.12 SAV-IOL SA 231 15.1.12.1 Business overview 231 15.1.12.2 Products offered 231 15.1.13 APPASAMY ASSOCIATES PRIVATE LIMITED 232 15.1.13.1 Business overview 232 15.1.13.2 Products offered 232 15.1.14 ATIA VISION, INC. 233 15.1.14.1 Business overview 233 15.1.14.2 Products offered 233 15.1.15 ADAPTILENS 234 15.1.15.1 Business overview 234 15.1.15.2 Products offered 234 15.2 OTHER PLAYERS 235 15.2.1 BIOTECH 235 15.2.2 TELEON SURGICAL BV 236 15.2.3 OMNI LENS PVT. LTD. 236 15.2.4 EYEKON MEDICAL 237 15.2.5 HUMANOPTICS HOLDING AG 237 15.2.6 CARE GROUP 238 15.2.7 SIFI S.P.A. 238 15.2.8 HANITA LENSES LTD. 239 15.2.9 EXCELLENT HI-CARE PVT LTD. 240 15.2.10 ADVIN HEALTH CARE 241 16 RESEARCH METHODOLOGY 242 16.1 RESEARCH DATA 242 16.1.1 SECONDARY DATA 242 16.1.1.1 Key data from secondary sources 244 16.1.2 PRIMARY DATA 244 16.1.2.1 Key data from primary sources 245 16.1.2.2 Key primary participants 246 16.1.2.3 Breakdown of primary interviews 246 16.1.2.4 Key industry insights 247 16.2 MARKET SIZE ESTIMATION 248 16.3 DATA TRIANGULATION 253 16.4 MARKET SHARE ESTIMATION 253 16.5 RESEARCH ASSUMPTIONS 254 16.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT 254 16.6.1 RESEARCH LIMITATIONS 254 16.6.2 RISK ASSESSMENT 254 17 APPENDIX 255 17.1 DISCUSSION GUIDE 255 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 259 17.3 CUSTOMIZATION OPTIONS 261 17.4 RELATED REPORTS 261 17.5 AUTHOR DETAILS 262

TABLE 1 INCLUSIONS AND EXCLUSIONS 27 TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2020–2024 28 TABLE 3 INTRAOCULAR LENS MARKET: INTERCONNECTED MARKETS 45 TABLE 4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 46 TABLE 5 INTRAOCULAR LENS MARKET: PORTER’S FIVE FORCES ANALYSIS 47 TABLE 6 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 50 TABLE 7 AVERAGE SELLING PRICE TREND OF INTRAOCULAR LENS, BY KEY PLAYER, 2022–2024 (USD) 56 TABLE 8 AVERAGE PRICING TREND OF INTRAOCULAR LENS, BY REGION, 2022–2024 (USD) 57 TABLE 9 IMPORT DATA FOR INTRAOCULAR LENS PRODUCTS UNDER HS CODE 900290, BY COUNTRY, 2020–2024 (USD THOUSAND) 58 TABLE 10 EXPORT DATA FOR INTRAOCULAR LENS UNDER HS CODE 900290, BY COUNTRY, 2020–2024 (USD THOUSAND) 58 TABLE 11 INTRAOCULAR LENS MARKET: KEY CONFERENCES AND EVENTS, 2025–2027 59 TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES 63 TABLE 13 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR INTRAOCULAR LENS 64 TABLE 14 INTRAOCULAR LENS MARKET: LIST OF PATENTS, 2022−2025 70 TABLE 15 TOP USE CASES AND MARKET POTENTIAL 73 TABLE 16 INTRAOCULAR LENS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 74 TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 75 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 22 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 23 GLOBAL STANDARDS IN INTRAOCULAR LENS MARKET 78 TABLE 24 INTRAOCULAR LENS MARKET: CERTIFICATIONS, LABELING, AND ECO-STANDARDS 80 TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INTRAOCULAR LENS, BY APPLICATION 82 TABLE 26 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 82 TABLE 27 INTRAOCULAR LENS MARKET: UNMET NEEDS/END-USER EXPECTATIONS 83 TABLE 28 INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 86 TABLE 29 MONOFOCAL INTRAOCULAR LENSES MARKET, BY TYPE, 2023–2030 (USD MILLION) 87 TABLE 30 MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 87 TABLE 31 MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (THOUSAND UNIT) 88 TABLE 32 ASPHERIC MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 89 TABLE 33 SPHERIC MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 90 TABLE 34 PREMIUM INTRAOCULAR LENSES MARKET, BY TYPE, 2023–2030 (USD MILLION) 92 TABLE 35 PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 36 PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (THOUSAND UNIT) 93 TABLE 37 MULTIFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 38 EXTENDED DEPTH OF FOCUS (EDOF) INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 39 ACCOMMODATING INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 40 PHAKIC INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 41 PHAKIC INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (THOUSAND UNIT) 98 TABLE 42 OTHER INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 43 INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 101 TABLE 44 INTRAOCULAR LENS MARKET FOR HYDROPHOBIC ACRYLIC IOL, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 45 INTRAOCULAR LENS MARKET FOR HYDROPHILIC ACRYLIC IOL, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 46 INTRAOCULAR LENS MARKET FOR POLYMETHYLMETHACRYLATE, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 47 INTRAOCULAR LENS MARKET FOR SILICONE IOL, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 48 INTRAOCULAR LENS MARKET FOR OTHER MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 49 INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 108 TABLE 50 INTRAOCULAR LENS MARKET FOR CATARACT SURGERIES, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 51 INTRAOCULAR LENS MARKET FOR PRESBYOPIA, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 52 INTRAOCULAR LENS MARKET FOR CORNEAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 53 INTRAOCULAR LENS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 54 INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 115 TABLE 55 INTRAOCULAR LENS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 56 INTRAOCULAR LENS MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 57 INTRAOCULAR LENS MARKET FOR EYE RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 58 INTRAOCULAR LENS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 59 INTRAOCULAR LENS MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 60 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 61 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 123 TABLE 62 NORTH AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE,2023–2030 (USD MILLION) 123 TABLE 63 NORTH AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 123 TABLE 64 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 124 TABLE 65 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 124 TABLE 66 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 124 TABLE 67 US: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 125 TABLE 68 US: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 126 TABLE 69 US: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 126 TABLE 70 US: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 126 TABLE 71 US: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127 TABLE 72 US: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 127 TABLE 73 CANADA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 128 TABLE 74 CANADA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 128 TABLE 75 CANADA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 128 TABLE 76 CANADA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 129 TABLE 77 CANADA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 129 TABLE 78 CANADA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 79 EUROPE: INTRAOCULAR LENS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 80 EUROPE: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 81 EUROPE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 131 TABLE 82 EUROPE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 131 TABLE 83 EUROPE: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 131 TABLE 84 EUROPE: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 132 TABLE 85 EUROPE: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 132 TABLE 86 GERMANY: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 87 GERMANY: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 88 GERMANY: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 89 GERMANY: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 134 TABLE 90 GERMANY: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 134 TABLE 91 GERMANY: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 134 TABLE 92 FRANCE: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 93 FRANCE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 94 FRANCE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 95 FRANCE: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 137 TABLE 96 FRANCE: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137 TABLE 97 FRANCE: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 98 UK: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138 TABLE 99 UK: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 100 UK: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 101 UK: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 139 TABLE 102 UK: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 103 UK: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 104 ITALY: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 105 ITALY: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 106 ITALY: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 107 ITALY: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 142 TABLE 108 ITALY: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 142 TABLE 109 ITALY: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 142 TABLE 110 SPAIN: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 143 TABLE 111 SPAIN: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 143 TABLE 112 SPAIN: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 113 SPAIN: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 144 TABLE 114 SPAIN: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 144 TABLE 115 SPAIN: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 116 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 117 REST OF EUROPE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 118 REST OF EUROPE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 119 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 146 TABLE 120 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 121 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 122 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 123 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 124 ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 125 ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 126 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 150 TABLE 127 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 150 TABLE 128 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 129 JAPAN: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 130 JAPAN: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 131 JAPAN: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 132 JAPAN: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 152 TABLE 133 JAPAN: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153 TABLE 134 JAPAN: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 135 CHINA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 136 CHINA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 137 CHINA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 138 CHINA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 155 TABLE 139 CHINA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 155 TABLE 140 CHINA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 155 TABLE 141 INDIA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 142 INDIA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 143 INDIA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 144 INDIA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 157 TABLE 145 INDIA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 146 INDIA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 147 AUSTRALIA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 148 AUSTRALIA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 149 AUSTRALIA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 150 AUSTRALIA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 159 TABLE 151 AUSTRALIA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160 TABLE 152 AUSTRALIA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 153 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 154 SOUTH KOREA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 155 SOUTH KOREA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 156 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 162 TABLE 157 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 162 TABLE 158 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 159 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 160 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 161 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 162 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 164 TABLE 163 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 164 TABLE 164 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 165 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 166 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 167 LATIN AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 168 LATIN AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 169 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 167 TABLE 170 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 167 TABLE 171 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 172 BRAZIL: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 173 BRAZIL: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 174 BRAZIL: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 175 BRAZIL: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 169 TABLE 176 BRAZIL: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 169 TABLE 177 BRAZIL: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 178 MEXICO: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 179 MEXICO: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 180 MEXICO: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 181 MEXICO: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 171 TABLE 182 MEXICO: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172 TABLE 183 MEXICO: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 184 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 185 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE,2023–2030 (USD MILLION) 173 TABLE 186 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE,2023–2030 (USD MILLION) 173 TABLE 187 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 174 TABLE 188 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 174 TABLE 189 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 174 TABLE 190 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 191 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 192 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 193 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 176 TABLE 194 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176 TABLE 195 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 177 TABLE 196 GCC COUNTRIES: INTRAOCULAR LENS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 197 GCC COUNTRIES: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 198 GCC COUNTRIES: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 199 GCC COUNTRIES: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 179 TABLE 200 GCC COUNTRIES: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 179 TABLE 201 GCC COUNTRIES: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 202 KEY DEVELOPMENTS IN INTRAOCULAR LENS MARKET, JANUARY 2021–NOVEMBER 2025 180 TABLE 203 INTRAOCULAR LENS MARKET: DEGREE OF COMPETITION 184 TABLE 204 US INTRAOCULAR LENS MARKET: DEGREE OF COMPETITION 185 TABLE 205 INTRAOCULAR LENS MARKET: REGION FOOTPRINT 190   TABLE 206 INTRAOCULAR LENS MARKET: TYPE FOOTPRINT 191 TABLE 207 INTRAOCULAR LENS MARKET: MATERIAL FOOTPRINT 192 TABLE 208 INTRAOCULAR LENS MARKET: APPLICATION FOOTPRINT 193 TABLE 209 INTRAOCULAR LENS MARKET: END-USER FOOTPRINT 194 TABLE 210 INTRAOCULAR LENS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 197 TABLE 211 INTRAOCULAR LENS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 198 TABLE 212 INTRAOCULAR LENS MARKET: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2025 199 TABLE 213 INTRAOCULAR LENS MARKET: DEALS, JANUARY 2021–NOVEMBER 2025 201 TABLE 214 INTRAOCULAR LENS MARKET: EXPANSIONS, JANUARY 2021–NOVEMBER 2025 203 TABLE 215 ALCON: COMPANY OVERVIEW 204 TABLE 216 ALCON: PRODUCTS OFFERED 205 TABLE 217 ALCON: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–NOVEMBER 2025 206 TABLE 218 ALCON: DEALS, JANUARY 2021–NOVEMBER 2025 206 TABLE 219 JOHNSON & JOHNSON VISION CARE, INC.: COMPANY OVERVIEW 208 TABLE 220 JOHNSON & JOHNSON VISION CARE, INC.: PRODUCTS OFFERED 209 TABLE 221 JOHNSON & JOHNSON VISION CARE, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2025 210 TABLE 222 BAUSCH + LOMB: COMPANY OVERVIEW 211 TABLE 223 BAUSCH + LOMB: PRODUCTS OFFERED 212 TABLE 224 BAUSCH + LOMB: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–NOVEMBER 2025 213 TABLE 225 BAUSCH + LOMB: DEALS, JANUARY 2021–NOVEMBER 2025 213 TABLE 226 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW 215 TABLE 227 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED 216 TABLE 228 CARL ZEISS MEDITEC AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–NOVEMBER 2025 216 TABLE 229 CARL ZEISS MEDITEC AG: DEALS, JANUARY 2021–NOVEMBER 2025 217 TABLE 230 HOYA CORPORATION: COMPANY OVERVIEW 218 TABLE 231 HOYA CORPORATION: PRODUCTS OFFERED 219 TABLE 232 HOYA CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2025 220 TABLE 233 SANTEN PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 221 TABLE 234 SANTEN PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED 222 TABLE 235 NIDEK CO., LTD.: COMPANY OVERVIEW 223 TABLE 236 NIDEK CO., LTD.: PRODUCTS OFFERED 223 TABLE 237 NIDEK CO., LTD.: DEALS, JANUARY 2021–NOVEMBER 2025 224 TABLE 238 LENSTEC, INC.: COMPANY OVERVIEW 225 TABLE 239 LENSTEC, INC.: PRODUCTS OFFERED 225 TABLE 240 LENSTEC, INC.: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2025 225 TABLE 241 RAYNER GROUP: COMPANY OVERVIEW 226 TABLE 242 RAYNER GROUP: PRODUCTS OFFERED 226 TABLE 243 RAYNER GROUP: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–NOVEMBER 2025 227   TABLE 244 BVI: COMPANY OVERVIEW 228 TABLE 245 BVI: PRODUCTS OFFERED 228 TABLE 246 BVI: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–NOVEMBER 2025 229 TABLE 247 BVI: DEALS, JANUARY 2021–NOVEMBER 2025 229 TABLE 248 BVI: EXPANSIONS, JANUARY 2021–NOVEMBER 2025 229 TABLE 249 OPHTEC B.V.: COMPANY OVERVIEW 230 TABLE 250 OPHTEC B.V.: PRODUCTS OFFERED 230 TABLE 251 SAV-IOL SA: COMPANY OVERVIEW 231 TABLE 252 SAV-IOL SA: PRODUCTS OFFERED 231 TABLE 253 APPASAMY ASSOCIATES PRIVATE LIMITED: COMPANY OVERVIEW 232 TABLE 254 APPASAMY ASSOCIATES PRIVATE LIMITED: PRODUCTS OFFERED 232 TABLE 255 ATIA VISION, INC.: COMPANY OVERVIEW 233 TABLE 256 ATIA VISION, INC.: PRODUCTS OFFERED 233 TABLE 257 ADAPTILENS: COMPANY OVERVIEW 234 TABLE 258 ADAPTILENS: PRODUCTS OFFERED 234 TABLE 259 BIOTECH: COMPANY OVERVIEW 235 TABLE 260 TELEON SURGICAL BV: COMPANY OVERVIEW 236 TABLE 261 OMNI LENS PVT. LTD.: COMPANY OVERVIEW 236 TABLE 262 EYEKON MEDICAL: COMPANY OVERVIEW 237 TABLE 263 HUMANOPTICS HOLDING AG: COMPANY OVERVIEW 237 TABLE 264 CARE GROUP: COMPANY OVERVIEW 238 TABLE 265 SIFI S.P.A.: COMPANY OVERVIEW 238 TABLE 266 HANITA LENSES LTD.: COMPANY OVERVIEW 239 TABLE 267 EXCELLENT HI-CARE PVT. LTD.: COMPANY OVERVIEW 240 TABLE 268 ADVIN HEALTH CARE: COMPANY OVERVIEW 241 TABLE 269 INTRAOCULAR LENS MARKET: RESEARCH ASSUMPTIONS 254 TABLE 270 INTRAOCULAR LENS MARKET: RISK ASSESSMENT 254 FIGURE 1 INTRAOCULAR LENS MARKET SEGMENTATION AND REGIONAL SCOPE 26 FIGURE 2 MARKET SCENARIO 30 FIGURE 3 INTRAOCULAR LENS MARKET, 2025–2030 30 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN INTRAOCULAR LENS MARKET (2020–2025) 31 FIGURE 5 DISRUPTIVE TRENDS INFLUENCING GROWTH OF INTRAOCULAR LENS MARKET 32 FIGURE 6 HIGH-GROWTH SEGMENTS IN INTRAOCULAR LENS MARKET 33 FIGURE 7 NORTH AMERICA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 34 FIGURE 8 INCREASING INCIDENCE OF CHRONIC DISEASES AND SUBSEQUENT RISE IN CATARACT SURGERIES TO DRIVE MARKET 35 FIGURE 9 HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024 36 FIGURE 10 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 37 FIGURE 11 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 37 FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 38 FIGURE 13 INTRAOCULAR LENS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39 FIGURE 14 GLOBAL DISTANCE VISION IMPAIRMENT STATISTICS, 2023 41 FIGURE 15 INTRAOCULAR LENS MARKET: PORTER’S FIVE FORCES ANALYSIS 48 FIGURE 16 INTRAOCULAR LENS MARKET: SUPPLY CHAIN ANALYSIS 53 FIGURE 17 INTRAOCULAR LENS MARKET: VALUE CHAIN ANALYSIS 53 FIGURE 18 INTRAOCULAR LENS MARKET: ECOSYSTEM ANALYSIS 55 FIGURE 19 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN INTRAOCULAR LENS MARKET 60 FIGURE 20 INTRAOCULAR LENS MARKET: INVESTMENT AND FUNDING SCENARIO 60 FIGURE 21 INTRAOCULAR LENS MARKET: PATENT ANALYSIS, JANUARY 2015–NOVEMBER 2025 69 FIGURE 22 TOP APPLICANTS FOR INTRAOCULAR LENS, BY COUNTRY/REGION, JANUARY 2015− NOVEMBER 2025 70 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INTRAOCULAR LENS, BY APPLICATION 81 FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 82 FIGURE 25 NORTH AMERICA: INTRAOCULAR LENS MARKET SNAPSHOT 122 FIGURE 26 ASIA PACIFIC: INTRAOCULAR LENS MARKET SNAPSHOT 148 FIGURE 27 REVENUE ANALYSIS OF TOP PLAYERS IN INTRAOCULAR LENS MARKET, 2020–2024 (USD MILLION) 182 FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 183 FIGURE 29 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 184 FIGURE 30 INTRAOCULAR LENS MARKET: BRAND/PRODUCT COMPARISON 186 FIGURE 31 INTRAOCULAR LENS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 188   FIGURE 32 INTRAOCULAR LENS MARKET: COMPANY FOOTPRINT 189 FIGURE 33 INTRAOCULAR LENS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 196 FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 198 FIGURE 35 EV/EBITDA OF KEY VENDORS 199 FIGURE 36 ALCON: COMPANY SNAPSHOT (2024) 205 FIGURE 37 JOHNSON & JOHNSON VISION CARE, INC.: COMPANY SNAPSHOT (2024) 209 FIGURE 38 BAUSCH + LOMB: COMPANY SNAPSHOT (2024) 212 FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2024) 215 FIGURE 40 HOYA CORPORATION: COMPANY SNAPSHOT (2024) 219 FIGURE 41 SANTEN PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT (2024) 221 FIGURE 42 RESEARCH DESIGN 242 FIGURE 43 PRIMARY SOURCES 244 FIGURE 44 KEY PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS 246 FIGURE 45 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 246 FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 247 FIGURE 47 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 248 FIGURE 48 REVENUE SHARE ANALYSIS ILLUSTRATION: ALCON, INC. 249 FIGURE 49 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES (2024) 249 FIGURE 50 INTRAOCULAR LENS MARKET: TOP-DOWN APPROACH 250 FIGURE 51 DEMAND-SIDE MARKET ESTIMATION FOR INTRAOCULAR LENSES 251 FIGURE 52 INTRAOCULAR LENS MARKET: CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2030) 252 FIGURE 53 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 252 FIGURE 54 DATA TRIANGULATION 253